{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T03:58:57Z","timestamp":1779249537941,"version":"3.51.4"},"reference-count":48,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009015","name":"Abbott Japan Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002336","name":"Daiichi Sankyo Co Ltd","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences Corp","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","journal-of-cardiology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.jjcc.2023.07.012","type":"journal-article","created":{"date-parts":[[2023,7,29]],"date-time":"2023-07-29T11:24:00Z","timestamp":1690629840000},"page":"141-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["What is the current optimal antithrombotic therapy after transcatheter aortic valve implantation? Current evidence from Japan and the world"],"prefix":"10.1016","volume":"83","author":[{"given":"Yusuke","family":"Kobari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kentaro","family":"Hayashida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"24","key":"10.1016\/j.jjcc.2023.07.012_bb0005","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1161\/01.CIR.0000047200.36165.B8","article-title":"Percutaneous transcatheter implantation of an aortic valve prosthesis for calcific aortic stenosis: first human case description","volume":"106","author":"Cribier","year":"2002","journal-title":"Circulation."},{"issue":"18","key":"10.1016\/j.jjcc.2023.07.012_bb0010","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jjcc.2023.07.012_bb0015","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jjcc.2023.07.012_bb0020","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.jjcc.2023.07.012_bb0025","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT registry of transcatheter aortic valve replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"10.1016\/j.jjcc.2023.07.012_bb0030","doi-asserted-by":"crossref","first-page":"e1549","DOI":"10.4244\/EIJ-D-18-01010","article-title":"Transcatheter aortic valve implantation (TAVI) in Germany: more than 100,000 procedures and now the standard of care for the elderly","volume":"14","author":"Eggebrecht","year":"2019","journal-title":"EuroIntervention."},{"key":"10.1016\/j.jjcc.2023.07.012_bb0035","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s12928-022-00893-9","article-title":"OCEAN-TAVI Registry. Antithrombotic therapy after transcatheter aortic valve replacement","volume":"38","author":"Kobari","year":"2023","journal-title":"Cardiovasc Interv Ther"},{"issue":"16","key":"10.1016\/j.jjcc.2023.07.012_bb0040","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1016\/j.jacc.2019.08.1032","article-title":"Thrombotic versus bleeding risk after transcatheter aortic valve replacement: JACC review topic of the week","volume":"74","author":"Mangieri","year":"2019","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.012_bb0045","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1001\/jamacardio.2019.4367","article-title":"Adjunctive antithrombotic therapy for patients with aortic stenosis undergoing transcatheter aortic valve replacement","volume":"5","author":"Saito","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0050","doi-asserted-by":"crossref","DOI":"10.1136\/openhrt-2020-001269","article-title":"Impact of beta blockers on patients undergoing transcatheter aortic valve replacement: the OCEAN-TAVI registry","volume":"7","author":"Saito","year":"2020","journal-title":"Open Heart"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.012_bb0055","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.ejcts.2007.03.031","article-title":"Antiplatelet therapy early after bioprosthetic aortic valve replacement is unnecessary in patients without thromboembolic risk factors","volume":"32","author":"Brueck","year":"2007","journal-title":"Eur J Cardiothorac Surg"},{"issue":"11","key":"10.1016\/j.jjcc.2023.07.012_bb0060","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jcin.2022.04.018","article-title":"Long-term follow-up of hypoattenuated leaflet thickening after transcatheter aortic valve replacement","volume":"15","author":"Hein","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"10.1016\/j.jjcc.2023.07.012_bb0065","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.jcin.2021.11.028","article-title":"Short duration of DAPT versus de-escalation after percutaneous coronary intervention for acute coronary syndromes","volume":"15","author":"Laudani","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0070","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s12928-022-00847-1","article-title":"Antiplatelet therapy after percutaneous coronary intervention: current status and future perspectives","volume":"37","author":"Natsuaki","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0075","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s12928-021-00771-w","article-title":"Prasugrel switching from clopidogrel after percutaneous coronary intervention for acute coronary syndrome in Taiwanese patients: an analysis of safety and efficacy","volume":"37","author":"Liu","year":"2022","journal-title":"Cardiovasc Interv Ther"},{"issue":"23 Pt A","key":"10.1016\/j.jjcc.2023.07.012_bb0080","doi-asserted-by":"crossref","first-page":"2915","DOI":"10.1016\/j.jacc.2018.09.057","article-title":"ACC\/AHA versus ESC guidelines on dual antiplatelet therapy: JACC guideline comparison","volume":"72","author":"Capodanno","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"16","key":"10.1016\/j.jjcc.2023.07.012_bb0085","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.4244\/EIJ-D-21-00721","article-title":"Safety and efficacy of ticagrelor monotherapy according to drug-eluting stent type: the TWILIGHT-STENT study","volume":"17","author":"Dangas","year":"2022","journal-title":"EuroIntervention."},{"issue":"13","key":"10.1016\/j.jjcc.2023.07.012_bb0090","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/j.jcin.2017.04.014","volume":"10","author":"Rodes-Cabau","year":"2017","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.jjcc.2023.07.012_bb0095","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1056\/NEJMoa2017815","article-title":"Aspirin with or without clopidogrel after transcatheter aortic-valve implantation","volume":"383","author":"Brouwer","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0100","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.amjcard.2018.04.006","article-title":"Meta-analysis comparing single versus dual antiplatelet therapy following transcatheter aortic valve implantation","volume":"122","author":"Maes","year":"2018","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jjcc.2023.07.012_bb0105","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1016\/j.amjcard.2011.07.049","article-title":"Dual antiplatelet therapy versus aspirin alone in patients undergoing transcatheter aortic valve implantation","volume":"108","author":"Ussia","year":"2011","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jjcc.2023.07.012_bb0110","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/heartjnl-2016-309735","article-title":"Pre-procedural dual antiplatelet therapy in patients undergoing transcatheter aortic valve implantation increases risk of bleeding","volume":"103","author":"Hioki","year":"2017","journal-title":"Heart."},{"issue":"7","key":"10.1016\/j.jjcc.2023.07.012_bb0115","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0120","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1911425","article-title":"A controlled trial of rivaroxaban after transcatheter aortic-valve replacement","volume":"382","author":"Dangas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jjcc.2023.07.012_bb0125","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.ahj.2018.03.008","article-title":"Oral anti-Xa anticoagulation after trans-aortic valve implantation for aortic stenosis: the randomized ATLANTIS trial","volume":"200","author":"Collet","year":"2018","journal-title":"Am Heart J"},{"issue":"10 Pt A","key":"10.1016\/j.jjcc.2023.07.012_bb0130","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1016\/j.jcmg.2016.11.020","article-title":"A highly predictive risk model for pacemaker implantation after TAVR","volume":"10","author":"Maeno","year":"2017","journal-title":"JACC Cardiovasc Imaging"},{"issue":"29","key":"10.1016\/j.jjcc.2023.07.012_bb0135","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1093\/eurheartj\/ehac242","article-title":"Apixaban vs. standard of care after transcatheter aortic valve implantation: the ATLANTIS trial","volume":"43","author":"Collet","year":"2022","journal-title":"Eur Heart J"},{"issue":"6","key":"10.1016\/j.jjcc.2023.07.012_bb0140","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1161\/CIRCULATIONAHA.122.059512","article-title":"Edoxaban versus dual antiplatelet therapy for leaflet thrombosis and cerebral thromboembolism after TAVR: the ADAPT-TAVR randomized clinical trial","volume":"146","author":"Park","year":"2022","journal-title":"Circulation."},{"issue":"9","key":"10.1016\/j.jjcc.2023.07.012_bb0145","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1056\/NEJMoa1007432","article-title":"Apixaban in patients with atrial fibrillation","volume":"364","author":"Connolly","year":"2011","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jjcc.2023.07.012_bb0150","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1056\/NEJMoa1915152","article-title":"Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation","volume":"382","author":"Nijenhuis","year":"2020","journal-title":"N Engl J Med"},{"issue":"22","key":"10.1016\/j.jjcc.2023.07.012_bb0155","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1056\/NEJMoa1310907","article-title":"Edoxaban versus warfarin in patients with atrial fibrillation","volume":"369","author":"Giugliano","year":"2013","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/j.jjcc.2023.07.012_bb0160","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jjcc.2023.07.012_bb0165","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"23","key":"10.1016\/j.jjcc.2023.07.012_bb0170","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"issue":"10087","key":"10.1016\/j.jjcc.2023.07.012_bb0175","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1016\/S0140-6736(17)30757-2","article-title":"Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study","volume":"389","author":"Chakravarty","year":"2017","journal-title":"Lancet"},{"issue":"24","key":"10.1016\/j.jjcc.2023.07.012_bb0180","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1016\/j.jcin.2021.09.019","article-title":"Subclinical leaflet thrombosis after transcatheter aortic valve replacement: a meta-analysis","volume":"14","author":"Bogyi","year":"2021","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.jjcc.2023.07.012_bb0185","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.026334","article-title":"Natural history of leaflet thrombosis after transcatheter aortic valve replacement: a 5-year follow-up study","volume":"11","author":"Imaeda","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"4","key":"10.1016\/j.jjcc.2023.07.012_bb0190","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.jacc.2020.11.018","article-title":"2020 ACC\/AHA guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Joint Committee on Clinical Practice Guidelines","volume":"77","author":"Otto","year":"2021","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jjcc.2023.07.012_bb0195","doi-asserted-by":"crossref","first-page":"2739","DOI":"10.1093\/eurheartj\/ehx391","article-title":"2017 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"38","author":"Baumgartner","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/j.jjcc.2023.07.012_bb0200","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.amjcard.2020.11.017","article-title":"The impact of baseline thrombocytopenia on late bleeding and mortality after transcatheter aortic valve implantation (from the Japanese Multicenter OCEAN-TAVI Registry)","volume":"141","author":"Ito","year":"2021","journal-title":"Am J Cardiol"},{"issue":"3","key":"10.1016\/j.jjcc.2023.07.012_bb0205","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1161\/CIRCULATIONAHA.119.040167","article-title":"Defining high bleeding risk in patients undergoing percutaneous coronary intervention","volume":"140","author":"Urban","year":"2019","journal-title":"Circulation."},{"issue":"5","key":"10.1016\/j.jjcc.2023.07.012_bb0210","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCINTERVENTIONS.120.010097","article-title":"Aspirin versus clopidogrel as single antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry","volume":"14","author":"Kobari","year":"2021","journal-title":"Circ Cardiovasc Interv"},{"issue":"22","key":"10.1016\/j.jjcc.2023.07.012_bb0215","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1016\/j.jcin.2020.09.013","article-title":"Direct oral anticoagulants versus vitamin K antagonists in patients with atrial fibrillation after TAVR","volume":"13","author":"Kawashima","year":"2020","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"10.1016\/j.jjcc.2023.07.012_bb0220","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s00380-020-01693-y","article-title":"Short-term dual anti-platelet therapy decreases long-term cardiovascular mortality after transcatheter aortic valve replacement","volume":"36","author":"Hioki","year":"2021","journal-title":"Heart Vessels"},{"issue":"3","key":"10.1016\/j.jjcc.2023.07.012_bb0225","doi-asserted-by":"crossref","DOI":"10.1093\/ehjopen\/oeab036","article-title":"Academic research consortium high bleeding risk criteria associated with 2-year bleeding events and mortality after transcatheter aortic valve replacement discharge: a Japanese multicentre prospective OCEAN-TAVI Registry study","volume":"1","author":"Mizutani","year":"2021","journal-title":"Eur Heart J Open"},{"issue":"11","key":"10.1016\/j.jjcc.2023.07.012_bb0230","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1253\/circj.CJ-22-0093","article-title":"Edoxaban vs. vitamin K antagonist for atrial fibrillation after transcatheter aortic valve replacement in Japanese patients \u2014 a subanalysis of the ENVISAGE-TAVI AF trial","volume":"86","author":"Watanabe","year":"2022","journal-title":"Circ J"},{"issue":"1","key":"10.1016\/j.jjcc.2023.07.012_bb0235","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.jcin.2022.10.010","article-title":"No antithrombotic therapy after transcatheter aortic valve replacement: insight from the OCEAN-TAVI Registry","volume":"16","author":"Kobari","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"15","key":"10.1016\/j.jjcc.2023.07.012_bb0240","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1016\/j.jcin.2021.06.020","article-title":"Antithrombotic therapy after transcatheter aortic valve replacement","volume":"14","author":"Capodanno","year":"2021","journal-title":"JACC Cardiovasc Interv"}],"container-title":["Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872300179X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S091450872300179X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T13:09:55Z","timestamp":1760274595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S091450872300179X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S091450872300179X"],"URL":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.07.012","relation":{},"ISSN":["0914-5087"],"issn-type":[{"value":"0914-5087","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is the current optimal antithrombotic therapy after transcatheter aortic valve implantation? Current evidence from Japan and the world","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jjcc.2023.07.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}